Non-NODAT | NODAT | P value | |
---|---|---|---|
Number of patients (%) | 333 (79.6) | 85 (20.4) | |
Age (years) | 40.85 ± 10.54 | 47.82 ± 10.75 | <0.001 |
Sex, male (%) | 176 (52.9) | 53 (62.4) | 0.143 |
BMI, pre-transplantation (kg/m2) | 21.9 ± 3.0 | 24.1 ± 3.2 | <0.001 |
BMI category, pre-transplantation(%) | |||
≥ 18.5 kg/m2 | 293 (88.0) | 84 (98.8) | 0.004 |
≥ 25 kg/m2 | 50 (15.0) | 35 (41.2) | <0.001 |
≥ 30 kg/m2 | 2 (0.6) | 4 (4.7) | 0.017 |
≥ 35 kg/m2 | 1 (0.3) | 0 (0.0) | 0.797 |
Weight change | |||
14 days (kg) | 2.94 ± 3.54 | 3.51 ± 3.02 | 0.179 |
3 months (kg) | 0.67 ± 4.60 | 3.02 ± 4.87 | 0.002 |
Hypertension (%) | 301 (90.4) | 79 (92.9) | 0.534 |
Prior kidney transplantation (%) | 21 (6.3) | 4 (4.7) | 0.627 |
Donor Age (years) | 41.9 ± 10.9 | 42.3 ± 10.6 | 0.805 |
Donor Sex, male (%) | 181 (54.4) | 41 (48.2) | 0.332 |
Family history of diabetes mellitus (%) | |||
Any first degree relative | 49 (14.7) | 21 (24.7) | 0.036 |
One parent | 38 (11.4) | 12 (14.1) | 0.147 |
Both parents | 2 (0.6) | 1 (1.2) | 1.000 |
Sibling | 9 (2.7) | 8 (9.4) | 0.126 |
Cold ischemic time (minute) | 36.0 ± 19.6 | 40.0 ± 29.5 | 0.132 |
Rejection history within 1 year (%) | 24 (7.2) | 9 (10.6) | 0.365 |
Polycystic kidney disease (%) | 13 (3.9) | 7 (8.2) | 0.148 |
Immunosuppressive treatment | |||
Tacrolimus (%) | 230 (68.9) | 59 (69.4) | 1.000 |
Cyclosporine (%) | 104 (31.1) | 26 (30.6) | 1.000 |
Mycophenolate mofetil (%) | 273 (81.7) | 64 (75.3) | 0.181 |
Azathioprine (%) | 30 (9.0) | 11 (12.9) | 0.306 |
Corticosteroids (%) | 315 (94.3) | 83 (97.6) | 0.273 |
Tacrolimus level, 1 month (ng/mL) | 8.40 ± 3.01 | 8.45 ± 3.22 | 0.924 |
Tacrolimus level, 3 months (ng/mL) | 7.45 ± 2.58 | 7.25 ± 2.63 | 0.599 |
Cyclosporine level, 1 month (ng/mL) | 216.1 ± 89.6 | 219.9 ± 91.1 | 0.854 |
Cyclosporine level, 3 months (ng/mL) | 180.9 ± 79.6 | 157.5 ± 63.7 | 0.189 |
Corticosteroids dose, 1 month (mg) | 14.6 ± 3.90 | 14.9 ± 6.85 | 0.667 |
Corticosteroids total dose for 1 month (g) | 1.96 ± 0.37 | 1.95 ± 0.50 | 0.912 |
Corticosteroids dose, 3 months (mg) | 10.3 ± 3.12 | 9.8 ± 3.08 | 0.187 |
Corticosteroids total dose for 3 month (g) | 2.65 ± 0.50 | 2.63 ± 0.61 | 0.802 |
Mg supplementation, pre-transplantation (%) | 3 (0.9) | 0 (0) | 0.611 |
Serum magnesium level | |||
Pre-transplantation (mg/dL) | 2.17 ± 0.35 | 2.22 ± 0.34 | 0.213 |
7 days (mg/dL) | 1.94 ± 0.21 | 1.97 ± 0.23 | 0.270 |
1 month (mg/dL) | 1.80 ± 0.23 | 1.81 ± 0.23 | 0.897 |
3 month (mg/dL) | 1.82 ± 0.22 | 1.84 ± 0.23 | 0.641 |
Glucose, pre-transplantation (mg/dL) | 88.8 ± 10.4 | 95.7 ± 13.5 | <0.001 |
Total cholesterol (mg/dL) | 155.5 ± 35.7 | 161.9 ± 32.5 | 0.134 |
eGFR, 1 year (mL/min/1.73 m2) | 64.7 ± 19.7 | 61.2 ± 17.7 | 0.152 |
eGFR, 3 years (mL/min/1.73 m2) | 65.1 ± 21.5 | 59.4 ± 19.8 | 0.028 |